OBIO — Orchestra BioMed Holdings, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1814114 ·
Last close
$6.97
Market Cap
$548.57M
52W High
$7.45
52W Low
$3.46
ADV30
472,235
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 91,000 | 63,000 | -23,296,000 | -18,750,000 | 107,736,000 | 27,761,000 | 99,954,000 |
| Jun 2026 | 88,000 | 63,000 | -22,356,000 | -23,755,000 | 115,700,000 | 20,472,000 | 96,377,000 |
| Mar 2026 | 110,000 | 78,000 | -22,076,000 | -20,691,000 | 100,658,000 | 28,367,000 | 59,466,000 |
| Dec 2025 | 30,917,000 | 30,866,000 | 6,754,000 | 6,245,000 | 114,857,000 | 34,690,000 | 61,287,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-63,308,000
Investing CF
$-9,738,000
Financing CF
$58,795,000
CapEx
$-869,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.41
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-425,775,000
Inventory
$221,000
Receivables
$56,000
ST Investments
$74,146,000
EBIT TTM
$-53,711,000
Pretax Income TTM
$-56,951,000
Interest Exp TTM
$2,978,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,206,000
EBITDA
$-60,605,000
Free Cash Flow
$-37,931,752
Enterprise Value
$553,211,968
Total Cash
$101,907,000
Total Debt
$73,544,000
Shares Out
78,704,957
Trailing EPS
$-0.75
Book Value
$0.13
ROE
-182.3%
ROA
-35.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 33,482,000 | -51,807,000 | -52,701,000 | 114,857,000 | 61,287,000 | 53,570,000 | -48,963,000 |
| Dec 2024 | 2,638,000 | -64,301,000 | -61,024,000 | 76,173,000 | 43,215,000 | 32,958,000 | -50,558,000 |
| Dec 2023 | 2,760,000 | -51,506,000 | -49,120,000 | 95,212,000 | 27,169,000 | 68,043,000 | -46,127,000 |
| Dec 2022 | 3,533,000 | -32,657,000 | -33,608,000 | 95,572,000 | 43,038,000 | 52,534,000 | -29,289,000 |
TTM Snapshot
Revenues TTM
$31,976,000
NetIncome TTM
$-59,029,000
OpCashFlow TTM
—
Assets (Latest)
$115,700,000
Forward EPS
$-1.41
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $7.46 · call volume: 189 · put volume: 1
Expected Move to 2026-12-18:
±$1.30
(17.43%) —
implied range
$6.16 –
$8.76
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVHHL | AVITA Medical, Inc. | $549.85M | $3.50 | — |
| AVR | Anteris Technologies Global Corp. | $518.67M | $5.32 | — |
| SGHT | Sight Sciences, Inc. | $583.02M | $10.49 | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $583.56M | $26.05 | — |
| RCEL | AVITA Medical, Inc. | $495.50M | $15.77 | — |
News headlines (Yahoo Finance, 1h cache)
Orchestra BioMed to Participate in the Piper Sandler 38th Annual Healthcare Conference
2026-11-17 13:30 · Yahoo
Wall Street Analysts Think Orchestra BioMed Holdings, Inc. (OBIO) Could Surge 72.41%: Read This Before Placing a Bet
2026-11-16 13:55 · Yahoo
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Misses Revenue Estimates
2026-11-10 22:40 · Yahoo
Orchestra BioMed Announces Pricing of Public Offering
2026-11-06 03:42 · Yahoo
Orchestra BioMed Announces Proposed Public Offering
2026-11-05 21:01 · Yahoo
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
2026-10-29 12:30 · Yahoo
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
2026-10-22 12:30 · Yahoo
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
2026-10-01 12:00 · Yahoo
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?
2026-09-21 11:33 · Yahoo
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-27 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.